B6N-Tyrc-Brd/BrdCrCrl.FVB/N-Tg(K14-HPV38E6-E7)Tg/Tg187DKFZ/Jmar

Status

Under development - register interest

EMMA IDEM:15629
International strain nameB6N-Tyrc-Brd/BrdCrCrl.FVB/N-Tg(K14-HPV38E6-E7)Tg/Tg187DKFZ/Jmar
Alternative nameB6N-Tyrc-Brd/BrdCrCrl.FVB/N-Tg(K14-HPV38E6-E7)Tg/Tg187DKFZ/Jmar
Strain typeTransgenic Strains
Allele/Transgene symbolTg(KRT14- HPV38E6E7)187Jmar
Gene/Transgene symbolTg(KRT14- HPV38E6E7)187Jmar

Information from provider

ProviderJacqueline Marvel
Provider affiliationBatiment Franklin, CIRI INSERM U1111
Genetic informationTransgenic for the early genes E6 and E7 from the cutaneous papillomavirus type 38, under the control of the keratin 14 promoter, targeting their expression in the basal layer of epithelia. The transgene was transferred by backcross on the tyrosinase-mutated albino C57BL/6N mouse: B6N-Tyrc-Brd/BrdCrCrl. The mice are more susceptible to the development of UV-Induced tumors. The role of the immune system in this increased susceptibility is poorly understood. Hence, the backcross on C57BL/6 was performed for two reasons. First the study of the immune response in FVB mice, especially the T cells response, is relatively restricted compared to C57BL/6 where the array of tools to study T cells is very large. For example, MHC-tetramer and assorted pathogen or tumor-derived peptides allowing the follow-up of T cells dynamics and function are defined and broadly available for C57BL/6, but are not defined or available for FVB mice. Second to have access to the mutant lines that are mostly on a C57BL/6 background, having a Tg and a mutant (KO or other) on the same background simplifies the breeding strategy and reduces the number of mice used for an experiment. Reference for the original FVB/N-Tg(38E6E7)187DKFZ strain: Viarisio et al, Plos Pathogens, 2011 Jul7(7).
Phenotypic informationHomozygous:
Basal epithelial cells express the E6 and E7 genes from HPV38 (187Tg/Tg)

Heterozygous:
Basal epithelial cells express the E6 and E7 genes from HPV38 (187Tg/wt)
Breeding historyFVB/N-Tg(38E6E7)187Dkfz mice were backcrossed 10 times to B6 albino mice obtained from Charles River (B6N-Tyrc-Brd/BrdCrCrl). The positivity for the transgene was determined by PCR. After 10 backcrosses, heterozygous mice (187Tg/wt) were intercrossed to obtain homozygous transgenic mice (187Tg/Tg).
References
  • E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.;Viarisio Daniele, Mueller-Decker Karin, Kloz Ulrich, Aengeneyndt Birgit, Kopp-Schneider Annette, Gröne Hermann-Josef, Gheit Tarik, Flechtenmacher Christa, Gissmann Lutz, Tommasino Massimo, ;2011;PLoS pathogens;7;e1002125; 21779166
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredyes
Immunocompromisedno

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • absent skin pigmentation / MGI
  • absent coat pigmentation / MGI
  • decreased eye pigmentation / MGI

Literature references

  • E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.;Viarisio Daniele, Mueller-Decker Karin, Kloz Ulrich, Aengeneyndt Birgit, Kopp-Schneider Annette, Gröne Hermann-Josef, Gheit Tarik, Flechtenmacher Christa, Gissmann Lutz, Tommasino Massimo, ;2011;PLoS pathogens;7;e1002125; 21779166

Information on how we integrate external resources can be found here

Register interest

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).